These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3842636)

  • 41. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen.
    Noguchi M; Taniya T; Tajiri K; Miwa K; Miyazaki I; Koshino H; Mabuchi H; Nonomura A
    Br J Surg; 1987 Jul; 74(7):586-7. PubMed ID: 3620865
    [No Abstract]   [Full Text] [Related]  

  • 42. Fatal neutropenia associated with long-term tamoxifen therapy.
    Miké V; Currie VE; Gee TS
    Lancet; 1994 Aug; 344(8921):541-2. PubMed ID: 7914632
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessment of visual function for patients on tamoxifen.
    Duchesne GM
    Clin Oncol (R Coll Radiol); 1993; 5(2):128. PubMed ID: 8481363
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical significance of tamoxifen withdrawal response.
    Canney PA; Griffiths T; Latief TN; Priestman TJ
    Lancet; 1987 Jan; 1(8523):36. PubMed ID: 2879105
    [No Abstract]   [Full Text] [Related]  

  • 45. The patient's perspective.
    Goodare H
    Health Expect; 2006 Jun; 9(2):200-3. PubMed ID: 16677203
    [No Abstract]   [Full Text] [Related]  

  • 46. Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer.
    Yoon CI; Kim D; Ahn SG; Bae SJ; Cha C; Park S; Park S; Kim SI; Lee HS; Park JY; Jeong J
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agranulocytosis Induced by Tamoxifen in a Breast Cancer Patient.
    Herrscher H; Leblanc J; Petit T
    Breast Care (Basel); 2020 Feb; 15(1):72-74. PubMed ID: 32231501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer. Case report and review of the literature.
    Lauro S; Lalle M; D'Andrea MR; Vecchione A; Frati L
    Anticancer Res; 1994; 14(5B):2171-2. PubMed ID: 7840519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
    Gnant MF; Mlineritsch B; Luschin-Ebengreuth G; Grampp S; Kaessmann H; Schmid M; Menzel C; Piswanger-Soelkner JC; Galid A; Mittlboeck M; Hausmaninger H; Jakesz R;
    J Clin Oncol; 2007 Mar; 25(7):820-8. PubMed ID: 17159195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
    Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
    Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Sofrygin O; Thomas SK; Papo NL; Barghout V
    Clin Breast Cancer; 2007 Jun; 7(8):608-18. PubMed ID: 17592673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myelosuppression occurring after receiving tamoxifen for breast cancer. International Adjuvant Therapy Organisation.
    Br J Radiol; 1985 Dec; 58(696):1220. PubMed ID: 3842636
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.